Perspective Therapeutics (CATX) Other Non-Current Liabilities (2016 - 2026)

Perspective Therapeutics' Other Non-Current Liabilities history spans 16 years, with the latest figure at $437000.0 for Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities rose 201.38% to $437000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $437000.0, a 201.38% increase, with the full-year FY2025 number at $386000.0, up 601.82% from a year prior.
  • Other Non-Current Liabilities hit $437000.0 in Q1 2026 for Perspective Therapeutics, up from $386000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for CATX hit a ceiling of $668000.0 in Q3 2023 and a floor of $19000.0 in Q2 2024.
  • Historically, Other Non-Current Liabilities has averaged $418133.3 across 5 years, with a median of $437000.0 in 2026.
  • Biggest five-year swings in Other Non-Current Liabilities: tumbled 97.12% in 2024 and later skyrocketed 1394.74% in 2025.
  • Tracing CATX's Other Non-Current Liabilities over 5 years: stood at $657000.0 in 2022, then grew by 1.67% to $668000.0 in 2023, then crashed by 91.77% to $55000.0 in 2024, then soared by 601.82% to $386000.0 in 2025, then rose by 13.21% to $437000.0 in 2026.
  • Business Quant data shows Other Non-Current Liabilities for CATX at $437000.0 in Q1 2026, $386000.0 in Q4 2025, and $342000.0 in Q3 2025.